The interdisciplinary research team at the Johns Hopkins Center for the Advancement of HIV Neurotherapeutics (JH CAHN) is dedicated to studying such conditions as HIV-associated central nervous system (CNS) disorders. We aim to translate discoveries of the pathophysiological mechanisms of these conditions into novel therapeutics, as well as provide educational and clinical resources to other HIV researchers across Johns Hopkins Medicine institutions and beyond.
Our Cores
JH CAHN 2025 Symposium: Modern Translational Approaches to NeuroHIV
Tuesday, April 8, 2025 | 9:00 AM - 3:00 PM ET
Johns Hopkins University Owens Auditorium or virtually via Zoom
JH CAHN presents a one-day symposium where each core will share the latest research by guest speakers and pilot grant awardees. Invited speakers include:
- Avindra Nath, M.D., NINDS | Biotyping people with HIV based on viral and immune pathogenesis
- Sean Ekins, Ph.D., Collaborations Pharmaceuticals | AI / Machine Learning in Neuro HIV drug discovery
- Tricia Burdo, Ph.D., Rutgers | Biomarkers in NeuroHIV: Insights into immune activation and brain health
Funding Disclosure
The Johns Hopkins Center for the Advancement of HIV Neurotherapeutics (JH CAHN) is funded by a P30 Grant from the National Institute of Mental Health (P30MH075673). The content and research presented on this website is solely the responsibility of the authors and does not necessarily represent the views of the National Institutes of Health.